935-951
Review Article
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shaojun Shi and Ulrich Klotz
953-960
Review Article
Evidence for a pharmacogenetic adapted dose of oral anticoagulant in routine medical practice
Laurent Becquemont
961-966
Clinical Trial
Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
Luis Almeida, Amílcar Falcão, Manuel Vaz-da-Silva, Teresa Nunes and Ana-Teresa Santos, et al.
967-970
Pharmacogenetics
Relationship between
CYP2C8
genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers
P. Dorado, I. Cavaco, M. C. Cáceres, R. Piedade and V. Ribeiro, et al.
971-977
Pharmacogenetics
Relationships between specific serum IgE, IgG, IFN-γ level and IFN-γ, IFNR1 polymorphisms in patients with penicillin allergy
Na Gao, Hai-Ling Qiao, Lin-Jing Jia, Xin Tian and Yue-Wen Zhang
979-986
Pharmacogenetics
Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics
John W. J. Hinrichs, Harriët M. Loovers, Bart Scholten and Jan van der Weide
987-992
Pharmacokinetics and Disposition
Open AccessChloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria
Sue Jean Lee, Rose McGready, Christine Fernandez, Kasia Stepniewska and Moo Koo Paw, et al.
993-998
Pharmacokinetics and Disposition
Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration
L. T. Diem Thuy, L. Ngoc Hung, P. T. Danh and K. Na-Bangchang
999-1004
Pharmacoepidemiology and Prescription
Women encounter ADRs more often than do men
Y. Zopf, C. Rabe, A. Neubert, K. G. Gaßmann and W. Rascher, et al.
1005-1011
Pharmacoepidemiology and Prescription
Antibiotic prescribing patterns and hospital admissions with respiratory and urinary tract infections
Rocío Fernández Urrusuno, Miguel Pedregal González and Ma. Amparo Torrecilla Rojas
1013-1020
Pharmacoepidemiology and Prescription
Open AccessAntiepileptic drug utilization in children from 1997–2005—a study from the Netherlands
N. W. van de Vrie-Hoekstra, T. W. de Vries, P. B. van den Berg, O. F. Brouwer and L. T. W. de Jong-van den Berg
1021-1026
Pharmacoepidemiology and Prescription
Open AccessDiscontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials
Maurits E. L. Arbouw, Kris L. L. Movig, Henk-Jan Guchelaar, Petra J. E. Poels and Jeroen P. P. van Vugt, et al.
1027-1030
Short Communication
Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate
Wonku Kang, Kibum Kim, Eun-Young Kim, Kwang-il Kwon and Jun Seok Bang, et al.
1031-1032
Letter to the Editors
Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid
R. Cordoba, E. Ramirez, S. H. Lei, A. Lopez de la Guia and M. J. Sanjurjo, et al.
1033-1035
Letter to the Editors
No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam
D. Tomalik-Scharte, O. Doroshyenko, J. Kirchheiner, A. Jetter and A. Lazar, et al.